nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—Chloroprocaine—CHRNA10—nicotine dependence	0.062	0.892	CrCbGaD
Procainamide—SCN7A—cardiovascular system—nicotine dependence	0.0391	0.0808	CbGeAlD
Procainamide—DNMT1—cardiovascular system—nicotine dependence	0.0301	0.0621	CbGeAlD
Procainamide—SCN9A—midbrain—nicotine dependence	0.0239	0.0494	CbGeAlD
Procainamide—DNMT1—midbrain—nicotine dependence	0.0235	0.0485	CbGeAlD
Procainamide—SCN11A—brain—nicotine dependence	0.0226	0.0467	CbGeAlD
Procainamide—SCN5A—cardiovascular system—nicotine dependence	0.0212	0.0438	CbGeAlD
Procainamide—SCN1A—midbrain—nicotine dependence	0.0206	0.0425	CbGeAlD
Procainamide—SCN7A—brain—nicotine dependence	0.0192	0.0397	CbGeAlD
Procainamide—ACHE—midbrain—nicotine dependence	0.0191	0.0394	CbGeAlD
Procainamide—SCN2A—midbrain—nicotine dependence	0.0189	0.039	CbGeAlD
Procainamide—CHRM2—cardiovascular system—nicotine dependence	0.0181	0.0373	CbGeAlD
Procainamide—SCN8A—brain—nicotine dependence	0.0171	0.0354	CbGeAlD
Procainamide—SCN3A—midbrain—nicotine dependence	0.0166	0.0343	CbGeAlD
Procainamide—SCN9A—brain—nicotine dependence	0.015	0.0311	CbGeAlD
Procainamide—DNMT1—brain—nicotine dependence	0.0148	0.0305	CbGeAlD
Procainamide—Atrial fibrillation—Varenicline—nicotine dependence	0.0147	0.0512	CcSEcCtD
Procainamide—Arthritis—Varenicline—nicotine dependence	0.0143	0.0499	CcSEcCtD
Procainamide—Lethargy—Varenicline—nicotine dependence	0.0142	0.0495	CcSEcCtD
Procainamide—Psychotic disorder—Varenicline—nicotine dependence	0.0136	0.0474	CcSEcCtD
Procainamide—SCN4A—brain—nicotine dependence	0.0134	0.0277	CbGeAlD
Procainamide—SCN1A—brain—nicotine dependence	0.0129	0.0267	CbGeAlD
Procainamide—Abdominal pain upper—Varenicline—nicotine dependence	0.0127	0.0443	CcSEcCtD
Procainamide—BCHE—cardiovascular system—nicotine dependence	0.012	0.0248	CbGeAlD
Procainamide—ACHE—brain—nicotine dependence	0.012	0.0248	CbGeAlD
Procainamide—SCN2A—brain—nicotine dependence	0.0119	0.0245	CbGeAlD
Procainamide—Abdominal discomfort—Varenicline—nicotine dependence	0.0115	0.0402	CcSEcCtD
Procainamide—SCN10A—brain—nicotine dependence	0.0115	0.0237	CbGeAlD
Procainamide—Depression—Varenicline—nicotine dependence	0.0107	0.0373	CcSEcCtD
Procainamide—SCN3A—brain—nicotine dependence	0.0104	0.0216	CbGeAlD
Procainamide—SCN5A—brain—nicotine dependence	0.0104	0.0215	CbGeAlD
Procainamide—Bradycardia—Varenicline—nicotine dependence	0.00979	0.0342	CcSEcCtD
Procainamide—SLC22A5—midbrain—nicotine dependence	0.00963	0.0199	CbGeAlD
Procainamide—Hallucination—Varenicline—nicotine dependence	0.00957	0.0334	CcSEcCtD
Procainamide—BCHE—midbrain—nicotine dependence	0.00938	0.0194	CbGeAlD
Procainamide—SLC22A4—brain—nicotine dependence	0.00914	0.0189	CbGeAlD
Procainamide—Cardiac disorder—Varenicline—nicotine dependence	0.00893	0.0311	CcSEcCtD
Procainamide—CHRM2—brain—nicotine dependence	0.00886	0.0183	CbGeAlD
Procainamide—SLC22A1—brain—nicotine dependence	0.0087	0.018	CbGeAlD
Procainamide—Chills—Varenicline—nicotine dependence	0.00863	0.0301	CcSEcCtD
Procainamide—SLC22A3—brain—nicotine dependence	0.00832	0.0172	CbGeAlD
Procainamide—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00822	0.0515	CbGpPWpGaD
Procainamide—Dysgeusia—Varenicline—nicotine dependence	0.0082	0.0286	CcSEcCtD
Procainamide—Ill-defined disorder—Varenicline—nicotine dependence	0.00777	0.0271	CcSEcCtD
Procainamide—Angioedema—Varenicline—nicotine dependence	0.00765	0.0267	CcSEcCtD
Procainamide—Malaise—Varenicline—nicotine dependence	0.00755	0.0263	CcSEcCtD
Procainamide—Metoclopramide—DRD2—nicotine dependence	0.00748	0.108	CrCbGaD
Procainamide—Convulsion—Varenicline—nicotine dependence	0.00726	0.0253	CcSEcCtD
Procainamide—Arthralgia—Varenicline—nicotine dependence	0.00713	0.0249	CcSEcCtD
Procainamide—Myalgia—Varenicline—nicotine dependence	0.00713	0.0249	CcSEcCtD
Procainamide—Discomfort—Varenicline—nicotine dependence	0.00704	0.0246	CcSEcCtD
Procainamide—Shock—Varenicline—nicotine dependence	0.00672	0.0235	CcSEcCtD
Procainamide—Thrombocytopenia—Varenicline—nicotine dependence	0.00669	0.0233	CcSEcCtD
Procainamide—Anorexia—Varenicline—nicotine dependence	0.00651	0.0227	CcSEcCtD
Procainamide—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00641	0.0402	CbGpPWpGaD
Procainamide—Hypotension—Varenicline—nicotine dependence	0.00639	0.0223	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00623	0.0217	CcSEcCtD
Procainamide—SLC22A5—brain—nicotine dependence	0.00605	0.0125	CbGeAlD
Procainamide—Decreased appetite—Varenicline—nicotine dependence	0.00594	0.0207	CcSEcCtD
Procainamide—BCHE—brain—nicotine dependence	0.00589	0.0122	CbGeAlD
Procainamide—Feeling abnormal—Varenicline—nicotine dependence	0.00563	0.0196	CcSEcCtD
Procainamide—Gastrointestinal pain—Varenicline—nicotine dependence	0.00559	0.0195	CcSEcCtD
Procainamide—Urticaria—Varenicline—nicotine dependence	0.00543	0.0189	CcSEcCtD
Procainamide—Abdominal pain—Varenicline—nicotine dependence	0.0054	0.0188	CcSEcCtD
Procainamide—Body temperature increased—Varenicline—nicotine dependence	0.0054	0.0188	CcSEcCtD
Procainamide—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00509	0.0319	CbGpPWpGaD
Procainamide—Hypersensitivity—Varenicline—nicotine dependence	0.00504	0.0176	CcSEcCtD
Procainamide—Asthenia—Varenicline—nicotine dependence	0.0049	0.0171	CcSEcCtD
Procainamide—Pruritus—Varenicline—nicotine dependence	0.00484	0.0169	CcSEcCtD
Procainamide—Diarrhoea—Varenicline—nicotine dependence	0.00468	0.0163	CcSEcCtD
Procainamide—Dizziness—Varenicline—nicotine dependence	0.00452	0.0158	CcSEcCtD
Procainamide—Vomiting—Varenicline—nicotine dependence	0.00435	0.0152	CcSEcCtD
Procainamide—Nausea—Varenicline—nicotine dependence	0.00406	0.0142	CcSEcCtD
Procainamide—CYP2D6—brain—nicotine dependence	0.0039	0.00806	CbGeAlD
Procainamide—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00303	0.019	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00287	0.018	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00272	0.0171	CbGpPWpGaD
Procainamide—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00267	0.0167	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00256	0.016	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00243	0.0152	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00229	0.0143	CbGpPWpGaD
Procainamide—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00225	0.0141	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.0022	0.0138	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00217	0.0136	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00213	0.0134	CbGpPWpGaD
Procainamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00212	0.0132	CbGpPWpGaD
Procainamide—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00209	0.0131	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00209	0.0131	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00206	0.0129	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00202	0.0127	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00202	0.0127	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00197	0.0123	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.00196	0.0123	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00189	0.0118	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.00186	0.0117	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—CCAR1—nicotine dependence	0.00184	0.0115	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00184	0.0115	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00182	0.0114	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00176	0.011	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00175	0.011	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.00175	0.011	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00171	0.0107	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00168	0.0105	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00166	0.0104	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00163	0.0102	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00157	0.00982	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00157	0.0098	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00156	0.00979	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00155	0.0097	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—GABRA4—nicotine dependence	0.00151	0.00945	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0015	0.00942	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00146	0.00915	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.00145	0.00906	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00143	0.00896	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0014	0.00878	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0014	0.00875	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00137	0.00856	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—GABRA4—nicotine dependence	0.00135	0.00843	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.00134	0.00842	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0013	0.00816	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.00129	0.00808	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00128	0.00803	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00128	0.00799	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00126	0.00789	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00123	0.0077	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.0012	0.00753	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.0012	0.00751	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00115	0.00722	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00114	0.00716	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00114	0.00714	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00112	0.00703	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00112	0.00701	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0011	0.00692	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.0011	0.00686	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00107	0.00672	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00107	0.00671	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00106	0.00665	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00104	0.00654	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00103	0.00645	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00103	0.00643	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00102	0.00639	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.001	0.00628	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.000998	0.00625	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.000978	0.00612	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000966	0.00605	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.000965	0.00604	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000947	0.00593	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000935	0.00586	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000911	0.00571	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000911	0.0057	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000898	0.00563	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000876	0.00549	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.000873	0.00547	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.000861	0.00539	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000849	0.00532	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000814	0.0051	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.000781	0.00489	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000769	0.00482	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.000769	0.00481	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000716	0.00449	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000714	0.00447	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.000698	0.00437	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000651	0.00407	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000646	0.00405	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000624	0.00391	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000611	0.00383	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000602	0.00377	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000567	0.00355	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000556	0.00348	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000516	0.00323	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00049	0.00307	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.000482	0.00302	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000466	0.00292	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000445	0.00279	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000442	0.00277	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2A7—nicotine dependence	0.00038	0.00238	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2A7—nicotine dependence	0.000339	0.00212	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000337	0.00211	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000335	0.0021	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000303	0.0019	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000282	0.00177	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000263	0.00165	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000263	0.00165	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000239	0.0015	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000232	0.00145	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.00019	0.00119	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000173	0.00108	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000163	0.00102	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000157	0.000982	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000976	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000141	0.000884	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000102	0.000639	CbGpPWpGaD
